Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer's Disease-Modifying Therapy 2024-01-01
  2. Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease 2019-01-25
  3. Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge 2015-01-31

Studies

6 studies carry this tag.

Date range

2007 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Human brain mapping 1
  • NeuroImage 1
  • Neurobiology of aging 1
  • Neuroradiology 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer's Disease-Modifying Therapy

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. The journal of prevention of Alzheimer's disease 2024-01-01 Biomarkers

    A total of 428 participants were included; 167 had normal cognition, 245 had MCI, and 16 had mild AD.

  2. Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2019-01-25 Brain scans and imaging

    Optimized tau PET classifiers may diagnose AD with high accuracy, but both tau PET and structural brain MRI capture partly unique information relevant for the clinical deterioration in AD.

  3. Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. NeuroImage 2015-01-31 Brain scans and imaging

    Algorithms for computer-aided diagnosis of dementia based on structural MRI have demonstrated high performance in the literature, but are difficult to compare as different data sets and methodology were used for evaluation.

  4. Structural MRI changes detectable up to ten years before clinical Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2011-07-22 Brain scans and imaging

    Structural brain changes have been described in both mild cognitive impairment (MCI) and Alzheimer's disease (AD).

  5. Structural MRI biomarkers for preclinical and mild Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Human brain mapping 2009-10-01 Brain scans and imaging

    Noninvasive MRI biomarkers for Alzheimer's disease (AD) may enable earlier clinical diagnosis and the monitoring of therapeutic effectiveness.

  6. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuroradiology 2007-10-23 Brain scans and imaging

    Our findings support the notion that age at onset modulates the distribution of cortical involvement, and that disproportionate precuneus atrophy is more prominent in patients with a younger age of onset.

All topic tags with their study counts